Stock Scorer

Opko Health, Inc. (OPK)

Opko Health, Inc. reported revenue of 163.6M USD for the quarter ending 30 June 2026, up 4.3% from 156.8M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 163.6M +4.3%
Gross Profit Q2 '26 · ending 30 June 2026 80M +62.0%
Operating Income Q2 '26 · ending 30 June 2026 -7M —
Net Income Q2 '26 · ending 30 June 2026 -8.4M —
Cost of Revenue Q2 '26 · ending 30 June 2026 83.6M -22.2%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -43.5M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -46.5M —
Shares Outstanding Q2 '26 · ending 30 June 2026 755.3M +12.5%
EPS Q2 '26 · ending 30 June 2026 -0.09 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 606.9M-117.4M-225.7M-190.8M
20242024-12-31 713.1M-152.1M-53.2M-208.5M
20232023-12-31 863.5M-157M-188.9M-44.5M
20222022-12-31 1B-226.3M-328.4M-119.8M
20212021-12-31 1.8B18.8M-30.1M6.2M
20202020-12-31 1.4B57.7M30.6M5.8M
20192019-12-31 901.9M-274.1M-314.9M-185.3M
20182018-12-31 990.3M-171.2M-153M-137M
20172017-12-31 966M-276.4M-305.2M-138.6M
20162016-12-31 1.1B-96.6M-48.4M13.5M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30163.6M
Q1 '262026-03-31124.2M
Q4 '252025-12-31148.5M
Q3 '252025-09-30151.7M
Q2 '252025-06-30156.8M
Q1 '252025-03-31150M
Q4 '242024-12-31183.6M
Q3 '242024-09-30173.6M
Q2 '242024-06-30182.2M
Q1 '242024-03-31173.7M
Q4 '232023-12-31181.9M
Q3 '232023-09-30178.6M
Q2 '232023-06-30265.4M
Q1 '232023-03-31237.6M
Q4 '222022-12-31185.3M
Q3 '222022-09-30179.7M
Q2 '222022-06-30309.9M
Q1 '222022-03-31329.2M
Q4 '212021-12-31401.3M
Q3 '212021-09-30385.8M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-3080M
Q1 '262026-03-3145.8M
Q4 '252025-12-3164M
Q3 '252025-09-3049.9M
Q2 '252025-06-3049.4M
Q1 '252025-03-3142.6M
Q4 '242024-12-3184.7M
Q3 '242024-09-3040.1M
Q2 '242024-06-3051.7M
Q1 '242024-03-3142.1M
Q4 '132013-12-3156.6M
Q3 '132013-09-3039.6M
Q2 '132013-06-3041.8M
Q1 '132013-03-3119.6M
Q4 '122012-12-3126M
Q3 '122012-09-304.3M
Q2 '122012-06-303.7M
Q1 '122012-03-313.8M
Q4 '112011-12-311.6M
Q3 '112011-09-302.8M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-7M
Q1 '262026-03-31-51M
Q4 '252025-12-31-38.3M
Q3 '252025-09-3048.1M
Q2 '252025-06-30-60M
Q1 '252025-03-31-67.2M
Q4 '242024-12-31-33.1M
Q3 '242024-09-30-67.2M
Q2 '242024-06-30-61.7M
Q1 '242024-03-31-71.5M
Q4 '232023-12-31-69M
Q3 '232023-09-30-64.4M
Q2 '232023-06-307M
Q1 '232023-03-31-30.6M
Q4 '222022-12-31-55.3M
Q3 '222022-09-30-87.8M
Q2 '222022-06-30-10.7M
Q1 '222022-03-31-72.4M
Q3 '212021-09-3037.8M
Q2 '212021-06-305.6M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-8.4M
Q1 '262026-03-31-54.8M
Q4 '252025-12-31-31.3M
Q3 '252025-09-3021.6M
Q2 '252025-06-30-148.4M
Q1 '252025-03-31-67.6M
Q4 '242024-12-3114M
Q3 '242024-09-3024.9M
Q2 '242024-06-30-10.3M
Q1 '242024-03-31-81.8M
Q4 '232023-12-31-66.5M
Q3 '232023-09-30-84.5M
Q2 '232023-06-30-19.6M
Q1 '232023-03-31-18.3M
Q4 '222022-12-31-85.2M
Q3 '222022-09-30-86.1M
Q2 '222022-06-30-101.7M
Q1 '222022-03-31-55.4M
Q4 '212021-12-31-73.8M
Q3 '212021-09-3028.7M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3083.6M
Q1 '262026-03-3178.4M
Q4 '252025-12-3184.4M
Q3 '252025-09-30101.8M
Q2 '252025-06-30107.4M
Q1 '252025-03-31107.3M
Q4 '242024-12-3199M
Q3 '242024-09-30133.5M
Q2 '242024-06-30130.5M
Q1 '242024-03-31131.6M
Q2 '152015-06-3014.4M
Q1 '152015-03-3110.3M
Q3 '142014-09-3011.1M
Q2 '142014-06-3012.6M
Q1 '142014-03-3112.4M
Q3 '132013-09-3012M
Q2 '132013-06-3013.1M
Q1 '132013-03-3111.8M
Q4 '122012-12-318.8M
Q3 '122012-09-307.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-43.5M
Q1 '262026-03-31-19.3M
Q4 '252025-12-31-25.9M
Q3 '252025-09-30-34.6M
Q2 '252025-06-30-83.4M
Q1 '252025-03-31-34.6M
Q4 '242024-12-31-44.4M
Q3 '242024-09-30-77.1M
Q2 '242024-06-30-26.4M
Q1 '242024-03-31-35.6M
Q4 '232023-12-31-38.3M
Q3 '232023-09-3033.1M
Q2 '232023-06-30-365K
Q1 '232023-03-31-22.6M
Q4 '222022-12-31-31.6M
Q3 '222022-09-30-32.2M
Q2 '222022-06-30-11.5M
Q1 '222022-03-31-19.9M
Q4 '212021-12-31-5.6M
Q3 '212021-09-3033.4M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-46.5M
Q1 '262026-03-31-21.1M
Q4 '252025-12-31-28.6M
Q3 '252025-09-30-37.8M
Q2 '252025-06-30-86.7M
Q1 '252025-03-31-37.7M
Q4 '242024-12-31-49.8M
Q3 '242024-09-30-85M
Q2 '242024-06-30-33.7M
Q1 '242024-03-31-40M
Q4 '232023-12-31-41.3M
Q3 '232023-09-3028.9M
Q2 '232023-06-30-6.4M
Q1 '232023-03-31-25.7M
Q4 '222022-12-31-38M
Q3 '222022-09-30-39.8M
Q2 '222022-06-30-16.9M
Q1 '222022-03-31-25.1M
Q4 '212021-12-31-12.4M
Q3 '212021-09-3026.2M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30755.3M
Q1 '262026-03-31758.9M
Q3 '252025-09-30779.9M
Q2 '252025-06-30788M
Q1 '252025-03-31671.6M
Q3 '242024-09-30998.4M
Q2 '242024-06-30697.2M
Q1 '242024-03-31706.9M
Q3 '232023-09-30751.5M
Q2 '232023-06-30751.7M
Q1 '232023-03-31751.5M
Q3 '222022-09-30750.4M
Q2 '222022-06-30712.5M
Q1 '222022-03-31660.3M
Q3 '212021-09-30651.8M
Q2 '212021-06-30647M
Q1 '212021-03-31640.9M
Q3 '202020-09-30640.7M
Q2 '202020-06-30640.6M
Q2 '182018-06-30559.5M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.09
Q1 '262026-03-31-0.27
Q4 '252025-12-31-0.30
Q3 '252025-09-30-0.25
Q2 '252025-06-30-0.25
Q1 '252025-03-31-0.07
Q4 '242024-12-31-0.09
Q3 '242024-09-30-0.19
Q2 '242024-06-30-0.33
Q1 '242024-03-31-0.35
Q4 '232023-12-31-0.25
Q3 '232023-09-30-0.27
Q2 '232023-06-30-0.27
Q1 '232023-03-31-0.38
Q4 '222022-12-31-0.44
Q3 '222022-09-30-0.44
Q2 '222022-06-30-0.29
Q1 '222022-03-31-0.18
Q4 '212021-12-31-0.05
Q3 '212021-09-300.11